Sartorius Stedim Biotech S.A. (EPA:DIM)
France · Delayed Price · Currency is EUR 169.20
-0.90 (-0.53%)
Jul 31, 2026, 4:05 PM CET
Sartorius Stedim Biotech Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 16,550 | 20,432 | 18,360 | 22,074 | 27,881 | 44,467 | |
Market Cap Growth | -5.27% | 11.28% | -16.82% | -20.83% | -37.30% | 65.66% |
Enterprise Value | 18,759 | 22,641 | 20,588 | 25,674 | 28,974 | 44,946 |
Last Close Price | 169.20 | 210.00 | 188.70 | 239.50 | 302.50 | 482.40 |
PE Ratio | 56.51 | 76.92 | 104.25 | 71.07 | 31.81 | 107.20 |
Forward PE | 31.06 | 40.98 | 46.49 | 49.64 | 31.48 | 60.28 |
PEG Ratio | 1.92 | 1.86 | 2.29 | 6.24 | 1.67 | 6.53 |
PS Ratio | 5.51 | 6.89 | 6.60 | 7.95 | 7.98 | 15.40 |
PB Ratio | 3.90 | 5.00 | 4.61 | 8.37 | 11.38 | 26.85 |
P/TBV Ratio | - | - | - | - | 63.93 | 294.87 |
P/FCF Ratio | 41.97 | 68.34 | 38.63 | 80.91 | 153.44 | 117.67 |
P/OCF Ratio | 20.98 | 29.52 | 22.53 | 29.57 | 45.53 | 63.35 |
EV/Sales Ratio | 6.24 | 7.63 | 7.41 | 9.25 | 8.30 | 15.57 |
EV/EBITDA Ratio | 26.08 | 26.83 | 30.62 | 37.41 | 24.62 | 44.63 |
EV/EBIT Ratio | 33.57 | 43.07 | 55.55 | 57.12 | 29.11 | 51.94 |
EV/FCF Ratio | 47.57 | 75.72 | 43.32 | 94.11 | 159.46 | 118.94 |
Debt / Equity Ratio | 0.49 | 0.49 | 0.70 | 1.35 | 0.44 | 0.34 |
Debt / EBITDA Ratio | 3.34 | 3.08 | 4.27 | 5.37 | 0.97 | 0.62 |
Debt / FCF Ratio | 6.09 | 8.69 | 6.04 | 13.50 | 6.25 | 1.66 |
Net Debt / Equity Ratio | 0.52 | 0.53 | 0.55 | 1.35 | 0.42 | 0.24 |
Net Debt / EBITDA Ratio | 3.06 | 2.58 | 3.26 | 5.20 | 0.87 | 0.40 |
Net Debt / FCF Ratio | 5.58 | 7.27 | 4.61 | 13.07 | 5.66 | 1.06 |
Asset Turnover | 0.38 | 0.37 | 0.35 | 0.43 | 0.77 | 0.85 |
Inventory Turnover | 2.36 | 2.36 | 2.01 | 1.62 | 1.85 | 2.13 |
Quick Ratio | 0.41 | 0.44 | 1.01 | 0.44 | 0.49 | 0.56 |
Current Ratio | 1.16 | 1.02 | 1.85 | 1.51 | 1.61 | 1.40 |
Return on Equity (ROE) | 7.02% | 6.53% | 5.33% | 12.05% | 41.43% | 25.94% |
Return on Assets (ROA) | 5.03% | 4.61% | 3.78% | 5.47% | 17.18% | 16.29% |
Return on Invested Capital (ROIC) | 6.30% | 5.99% | 4.85% | 7.15% | 27.29% | 26.89% |
Return on Capital Employed (ROCE) | 8.39% | 7.57% | 5.25% | 8.31% | 28.67% | 33.27% |
Earnings Yield | 1.77% | 1.30% | 0.96% | 1.41% | 3.14% | 0.93% |
FCF Yield | 2.38% | 1.46% | 2.59% | 1.24% | 0.65% | 0.85% |
Dividend Yield | 0.41% | 0.33% | 0.37% | 0.60% | 0.42% | 0.14% |
Payout Ratio | 22.93% | 25.26% | 38.32% | 42.77% | 13.25% | 15.13% |
Buyback Yield / Dilution | 0.19% | -0.54% | -5.01% | 0.00% | 0.01% | 0.00% |
Total Shareholder Return | 0.59% | -0.21% | -4.64% | 0.60% | 0.43% | 0.14% |